Ludwig Jeffrey Jerome has filed 12 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 47841 shares of PUMA BIOTECHNOLOGY, INC. ($PBYI) on February 07, 2025.
Activity breakdown: 0 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 7, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | A | Common Stock | 47841 | $0.00 | 156,792.0000 | 49,100,433 | 43.91% | 0.10% |
| Feb. 7, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | A | Stock Option (Right to Buy) | 66221 | $0.00 | 66,221.0000 | 49,100,433 | 9999.99% | 0.13% |
| Jan. 2, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | S | Common Stock | 9437 | $3.15 | 108,951.0000 | 49,100,433 | 7.97% | 0.02% |
| July 17, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | S | Common Stock | 2598 | $3.70 | 118,388.0000 | 47,550,852 | 2.15% | 0.01% |
| July 2, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | S | Common Stock | 6051 | $3.27 | 120,986.0000 | 47,550,852 | 4.76% | 0.01% |
| Feb. 12, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | A | Common Stock | 27067 | $0.00 | 127,037.0000 | 47,550,852 | 27.08% | 0.06% |
| Feb. 12, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | A | Stock Option (Right to Buy) | 37466 | $0.00 | 37,466.0000 | 47,550,852 | 9999.99% | 0.08% |
| Jan. 3, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | S | Common Stock | 12956 | $4.49 | 99,970.0000 | 47,550,852 | 11.47% | 0.03% |
| July 3, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | S | Common Stock | 12103 | $3.31 | 112,926.0000 | 44,929,998 | 9.68% | 0.03% |
| Feb. 10, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | A | Common Stock | 66972 | $0.00 | 125,029.0000 | 44,929,998 | 115.36% | 0.15% |
| Feb. 10, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | A | Stock Option (Right to Buy) | 93028 | $0.00 | 93,028.0000 | 44,929,998 | 9999.99% | 0.21% |
| Jan. 3, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | S | Common Stock | 6568 | $4.18 | 58,057.0000 | 44,929,998 | 10.16% | 0.01% |